We are live on
!
Find out more
Myriad Genetics
MYGN
MYGN
221 hedge funds and large institutions have $568M invested in Myriad Genetics in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 85 increasing their positions, 75 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
19% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 26
13% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 75
3.82% more ownership
Funds ownership: 95.13% → 98.94% (+3.8%)
0% more funds holding
Funds holding: 221 → 221 (0)
11% less capital invested
Capital invested by funds: $640M → $568M (-$71.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
221
Holders Change
–
Holders Change %
0%
% of All Funds
2.69%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
85
Reduced
75
Closed
26
Calls
$352K
Puts
–
Net Calls
+$352K
Net Calls Change
-$463K
Top Buyers
| 1 |
Millennium Management
New York
|
+$14.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.18M |
| 3 |
VPC
Vestal Point Capital
New York
|
+$4.52M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.38M |
| 5 |
BlackRock
New York
|
+$3.08M |
Top Sellers
| 1 |
AG
Algert Global
San Francisco,
California
|
-$3.97M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$3.65M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.96M |
| 4 |
HF
HRT Financial
New York
|
-$2.33M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.27M |
